Product: CARBIDOPA AND LEVORDOPA TABLETS, USP  25MG/100MG 100 TABLETS; NDC/UPC 51862-856-01; RX; TABLETS
Reason for recall: CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Recall initiated: 20210315
Status: Terminated
Classification: Class II
Recall type: Voluntary: Firm initiated